Work

Resistance mechanisms in anaplastic lymphoma kinase-positive lung cancer

Year: 2025

Type: review

Source: Critical Reviews in Oncology/Hematology

DOI: 10.1016/j.critrevonc.2025.104821

Authors: Parnia Behinaein, Shirish M. Gadgeel, Ramandeep Rattan, Jeffrey P. MacKeigan, Amanda Pilling, Fawzi Abu Rous, Katie R. Martin, Ikenna C. Okereke

Institutions: Henry Ford Health, Henry Ford Hospital, Michigan State University

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Cancer Center, National Cancer Institute

Awards: G1303096710, ULK1 Inhibitor in Combination with Immune Checkpoint Blockade in PancreaticCancer, G322296414, Evaluating a Novel Autophagy Inhibitor in KRAS-Driven Lung Cancer, G5949951849, Therapeutic potential of targeting DNA repair deficiency in TSC, G8872170654, ULK Inhibition Rewires Tumor and Immune Cell Metabolism

OpenAlex ID: W4411715658

FWCI: 0.345

Cites: 58

Cited by: 2

Related to: 10